A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

BACKGROUND: The purpose of this study was to evaluate the efficacy and duration of action of once-daily dosing with alcaftadine 0.25% ophthalmic solution and olopatadine 0.2% ophthalmic solution as compared with placebo in the prevention of ocular itching, and to directly compare the efficacy of alc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackerman, Stacey, D’Ambrosio, Francis, Greiner, Jack V, Villanueva, Linda, Ciolino, Joseph B, Hollander, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792834/
https://www.ncbi.nlm.nih.gov/pubmed/24109191
http://dx.doi.org/10.2147/JAA.S38671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792834/
https://www.ncbi.nlm.nih.gov/pubmed/24109191
http://dx.doi.org/10.2147/JAA.S38671

Ejemplares similares